Cancer Is Especially Dangerous for Immigrants in Texas. Here ’s Why
McALLEN, Texas — Edgar carries a red folder bulging with paperwork, bills and medical records. Before his lung cancer diagnosis in September, he had about $11,000, he said, money he was saving to purchase a used truck and to pay an immigration attorney to pursue legal residency. By February, it was gone, and Edgar was relying on friends and family to cover doctor appointments, food and other basics. His treatment had been complicated by a collapsed lung. “I’m not able to work — I’m breathing with just one lung,” said the 50-year-old painter, who asked to be identified by only his first n...
Source: TIME: Health - April 22, 2019 Category: Consumer Health News Authors: Charlotte Huff / Kaiser Health News Tags: Uncategorized public health Source Type: news

A deep-learning model may help predict lung cancer survival and outcomes
(American Association for Cancer Research) A deep-learning model developed using serial image scans of tumors from patients with non-small cell lung cancer (NSCLC) predicted treatment response and survival outcomes better than standard clinical parameters. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 22, 2019 Category: Cancer & Oncology Source Type: news

Informational Film Improves Knowledge on Lung Cancer Screening
FRIDAY, April 19, 2019 -- An informational film can improve knowledge and reduce decisional conflict for individuals considering participating in lung cancer screening, according to a study published online April 19 in the Annals of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2019 Category: Pharmaceuticals Source Type: news

Want to Live Longer? Science Says to Do These 5 Things
When it comes to staying healthy, most people have the same motivation: living as long and fulfilling a life as possible. And while science has yet to find a true fountain of youth, researchers have identified certain behaviors that can increase longevity. One study, published in the journal Circulation last year, even argued that adhering to just five healthy habits could extend your lifespan by roughly a decade. Here’s what they are, and what research to date says about living your longest life. Eating a healthy diet Diet is strongly linked to longevity. Research has long suggested that following a Mediterranean di...
Source: TIME: Health - April 19, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Longevity Source Type: news

Can videos convince smokers to get CT lung screening?
Smokers who watched a video and read a brochure on the potential harms and...Read more on AuntMinnie.comRelated Reading: Prolonged CT lung screening offers cumulative benefits Doctors aren't discussing CT lung screening with patients Are patients adequately informed about CT lung screening? 4 reasons why people seek CT lung cancer screening Patient outreach may boost uptake for CT lung screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 19, 2019 Category: Radiology Source Type: news

Prolonged Lung Cancer Screening Boosts Mortality
Benefit (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 19, 2019 Category: General Medicine Source Type: news

Prolonged Lung Cancer Screening Boosts Mortality Benefit Prolonged Lung Cancer Screening Boosts Mortality Benefit
New data show that CT screening of individuals beyond 5 years can significantly increase survival benefits.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 19, 2019 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Crowdsourced AI learns to target lung tumors for radiation
(Reuters Health) - In many parts of the world there are not enough radiation oncologists to design and deliver radiation treatments for lung cancer patients, but that gap could one day be filled with the help of artificial intelligence, researchers suggest in a new study. (Source: Reuters: Health)
Source: Reuters: Health - April 18, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Circuit Clinical partners with Roswell Park for lung cancer clinical trials
Roswell Park patients will use Circuit Clinical's new TrialScout app to connect to clinical trial opportunities for the CIMIvax lung cancer vaccine. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 18, 2019 Category: American Health Authors: Tracey Drury Source Type: news

NRG Oncology receives $95M in NCI funding
The U.S. National Cancer Institute (NCI) has awarded funding of more than $95 million...Read more on AuntMinnie.comRelated Reading: NCI awards $15.5M for lung cancer screening NCI awards $8M grant for AI in radiology/pathology NCI awards $17M grant for breast imaging NCI publishes free organ dose calculator NCI awards grant for breast ultrasound CADx software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 17, 2019 Category: Radiology Source Type: news

State Medicaid Coverage for Lung Cancer Screening Is Spotty State Medicaid Coverage for Lung Cancer Screening Is Spotty
Medicaid coverage for lung cancer screening is highly variable among states and even within the same state, according to a new report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 17, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Lawsuits Put a Drag on J & amp;J 1Q19 Earnings
Legal costs surrounding Johnson and Johnson’s talc baby power and its blood thinner Xarleto bogged down the healthcare giant’s 1Q19 earnings. But while earnings from the New Brunswick, NJ-based company were down 14% from a year earlier, the firm managed to beat analyst expectations. J&J posted income of $3.75 billion or $1.39 per share for 1Q19. In 1Q18, the company brought in $4.37 billion or $1.60 per share. As a result, the healthcare company changed its full-year earnings forecast to a range of $8.53 to $8.63 a share, down from its previous estimate of between $8.50 and $8.65. Th...
Source: MDDI - April 16, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

EPA Removes Part of Libby Asbestos Cleanup from Superfund List
The U.S. Environmental Protection Agency has deleted a 45-acre portion of the Libby Asbestos Superfund site from the National Priorities List. The EPA and the Montana Department of Environmental Quality have agreed that institutional controls to prevent any future exposure to asbestos in the area were satisfied. It’s a step closer to finishing the decontamination of the longest-running, man-made environmental disaster in American history. The sprawling Superfund site, which was placed on the National Priorities List in 2002, was originally divided into eight operable units. The units were based upon the extent of co...
Source: Asbestos and Mesothelioma News - April 16, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Why ARE so many non-smokers dying of lung cancer?
Cases from lung cancer in non-smokers have doubled in the past seven years, and appears to be more common in women according to research from patients at the Royal Brompton Hospital. (Source: the Mail online | Health)
Source: the Mail online | Health - April 16, 2019 Category: Consumer Health News Source Type: news

The Risks of Getting a Tattoo Are Rare, But Real. Here ’s What to Know
Nearly three in 10 Americans have a tattoo, yet ink is still somewhat stigmatized. Many job seekers and office workers hide their body art rather than risk disapproval from higher-ups. Research also finds that tattoo stigma is widespread. A recent study, published in the journal Stigma and Health, found that when hypothetical patients with HIV or lung cancer had tattoos, others were more likely to blame them for their high health care costs compared to tattoo-free folks with the same illnesses. The study provides “initial evidence that tattooed individuals face health disparities,” the study authors write. Ta...
Source: TIME: Health - April 12, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Research Source Type: news

Cancer symptoms: The sign in your voice of the deadly disease - including lung cancer
CANCER symptoms can be extremely subtle and some are very surprising. For example, a certain sound in your voice can be a sign of cancers including lung cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - April 12, 2019 Category: Consumer Health News Source Type: news

Is It Too Soon to Augment Lung Cancer Screening Guidelines for High-Risk Patients?
A study looked at whether a  lung cancer risk prediction model could identify patients at high risk for lung cancer who could receive less frequent low-dose CT screening. (Source: CancerNetwork)
Source: CancerNetwork - April 12, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

CAR T-Cell Therapy for Mesothelioma Proving Effective in Clinical Trial
Dr. Prasad Adusumilli at Memorial Sloan Kettering Cancer Center believes novel CAR T-cell therapy will be part of future, standard-of-care treatment for malignant pleural mesothelioma. The therapy involves the laboratory reprograming of a patient’s T cells — a type of white blood cell — to attack the cancer by targeting mesothelin, a surface protein. CAR T-cell therapy is a form of immunotherapy that could extend mesothelioma survival significantly. “That’s my goal. That’s what we’ve been working toward for many years,” Adusumilli told The Mesothelioma Center at Asbestos.com....
Source: Asbestos and Mesothelioma News - April 11, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer
(European Society for Medical Oncology) Maintenance immunotherapy fails to improve survival in extensive-stage small cell lung cancer (SCLC), according to late-breaking results from the CheckMate 451 study to be presented today at the European Lung Cancer Congress (ELCC) 2019. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 11, 2019 Category: Cancer & Oncology Source Type: news

Should We Be Doing Molecular Testing at the Time of Acquired Resistance? Should We Be Doing Molecular Testing at the Time of Acquired Resistance?
A study of ALK-positive lung cancer raises questions about the role of repeat biopsies, as well as the relative value of tissue versus plasma molecular testing.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 10, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Capacity concerns over cancer pilot
NHS England has “questions to answer” about its lung cancer scanning pilots, as concerns have been raised over whether there will be enough diagnostic capacity to cope with the expected increase in referrals. (Source: HSJ)
Source: HSJ - April 10, 2019 Category: UK Health Source Type: news

Medical News Today: Chili pepper compound may slow down lung cancer
New research in mice and human cells suggests that capsaicin, the compound that gives red peppers its spicy flavor, may slow lung cancer progression. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 9, 2019 Category: Consumer Health News Tags: Lung Cancer Source Type: news

Single-cell sequencing reveals landscape of immune cell subtypes in lung cancer tumors
(Harvard Medical School) Single-cell sequencing reveals 25 subpopulations of myeloid cells, a poorly understood family of immune cells, in lung cancer tumors. Many subpopulations are similar across humans and mice, supporting the use of mouse models in immunotherapy research. Findings set stage to assess myeloid cells as targets for new or improved immunotherapies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 9, 2019 Category: International Medicine & Public Health Source Type: news

Lung cancer treatments vary among the Asian communities
In this study, rates of recommended care for non-small cell lung cancer were compared among patients in the Asian community. The authors concluded that practice patterns within different Asian ethnicities vary widely, and cultural and gender preferences appear to exist for different modalities of care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 9, 2019 Category: International Medicine & Public Health Source Type: news

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC
(European Society for Medical Oncology) Two studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC), where information has previously been lacking despite being the age group most commonly affected. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 9, 2019 Category: Cancer & Oncology Source Type: news

New Study Says Eating Chili Peppers Could Slow Lung Cancer Progression
BOSTON (CBS) — Lung cancer is the leading cause of cancer death in men and women but researchers at Marshall University found that a compound in spicy foods could help slow the spread of lung cancer. The compound is called capsaicin and gives chili peppers their heat, but it’s currently used in creams or patches to treat chronic pain. And now researchers are studying its potential anti-cancer properties. In a series of experiments, researchers found that capsaicin can inhibit the growth and proliferation of lung cancer cells and when mice were fed capsaicin they had smaller areas of metastatic cells in their lu...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 9, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Lung Cancer Source Type: news

Dogs can sniff out LUNG CANCER with 97% accuracy
Scientists at Florida-based pharmaceutical firm BioScent Dx taught three Beagles how to sniff out lung cancer in blood samples from human patients. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2019 Category: Consumer Health News Source Type: news

Osimertinib Plus Savolitinib Shows Activity in EGFR-Mutant, MET-Amplified NSCLC
Cancer Network spoke with Lecia V. Sequist, MD, MPH, about the TATTON study, which tested the combination of osimertinib and savolitinib in previously treated non –small-cell lung cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - April 8, 2019 Category: Cancer & Oncology Authors: Lecia V. Sequist, MD, MPH Source Type: news

Spicy compound from chili peppers slows lung cancer progression
(Experimental Biology) Findings from a new study show that the compound responsible for chili peppers' heat could help slow the spread of lung cancer, the leading cause of cancer death for both men and women. Most cancer-related deaths occur when cancer spreads to distant sites, a process called metastasis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2019 Category: Cancer & Oncology Source Type: news

CT lung screening uptake lags in rural areas
U.S. regions with the greatest proportion of smokers eligible for CT lung cancer...Read more on AuntMinnie.comRelated Reading: Sexual minorities overlooked in CT lung screening U.S. cancer sites boast high access to CT lung screening Access to CT lung screening varies by population density CT lung screening may benefit racial minorities most Patient outreach may boost uptake for CT lung screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 5, 2019 Category: Radiology Source Type: news

High-dose stereotactic body radiotherapy well-tolerated by patients with centrally located lung tumors
(NRG Oncology) Stereotactic body radiotherapy (SBRT), a high-dose, precisely delivered radiotherapy, is considered the standard treatment for patients with medically inoperable, node-negative, non-small cell lung cancer (NSCLC). However, this well-tolerated radiation treatment was not previously tested in centrally located NSCLC due to the fact that patients with centrally located lung tumors demonstrate a higher risk for toxicity if treated with high SBRT doses. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 5, 2019 Category: Cancer & Oncology Source Type: news

' Put Your Team Together'--Tumor Board Takeaways'Put Your Team Together'--Tumor Board Takeaways
Dr Kris details topics that are commonly discussed in his institution's lung cancer tumor board.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 4, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Report: Researchers create CT, MRI image-altering malware to expose vulnerabilities
A group of researchers have created a malware program designed to exploit vulnerabilities in computed tomography and magnetic resonance imaging equipment to add realistic, malignant-seeming growths to scans in a bid to draw attention to vulnerabilities in medical equipment networks, according to a Washington Post report. Researchers Yisroel Mirsky, Yuval Elovici and two others at the University Cyber Security Research Center in Israel created the malware program for use in a blinded study involving real CT scans, according to the report. A total of 70 images were altered by the malware and were able to fool three skilled r...
Source: Mass Device - April 3, 2019 Category: Medical Devices Authors: Fink Densford Tags: Featured Imaging Software / IT Source Type: news

The FDA Is Investigating a Possible Link Between Vaping and Seizures
E-cigarettes are often thought of as a less dangerous alternative to cigarettes, since they contain fewer lung-cancer-causing chemicals. But preliminary research has also shown health risks associated with nicotine-rich e-cigarettes, including a higher probability of heart and lung problems. Now, the Food and Drug Administration (FDA) is alerting Americans to a new potential health risk. Using e-cigarettes, also known as vaping, may be associated with seizures, especially among young people, the FDA announced Wednesday. The agency said it has received 35 reports of seizures following e-cigarette use since 2010. While the F...
Source: TIME: Health - April 3, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized public health Source Type: news

HOLNext-Generation Sequencing Assay Detects Genetic Variants Driving Cancer, Resistance in NSCLC HOLNext-Generation Sequencing Assay Detects Genetic Variants Driving Cancer, Resistance in NSCLC
A novel liquid biopsy based on ultra-deep next-generation sequencing (NGS) of plasma cell-free DNA (cfDNA) can detect oncogenic drivers and resistance mutations in non-small-cell lung cancer (NSCLC), even when tissue biopsy fails to do so, researchers say.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - April 3, 2019 Category: Pathology Tags: Hematology-Oncology News Source Type: news

AACR: Pembrolizumab Beneficial for Advanced Small Cell Lung Cancer
Antitumor activity promising; objective response rate 19.3 percent for patients with incurable, advanced SCLC (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 2, 2019 Category: Cancer & Oncology Tags: Oncology, Pulmonology, Conference News, Source Type: news

Johnson & Johnson closes Auris Health buyout, sterilization biz sale
Johnson & Johnson (NYSE:JNJ) said yesterday that its Ethicon biz completed its $3.4 billion acquisition of robotic surgery dev Auris Health and the $2.8 billion divestiture of its Advanced Sterilization Products to Fortive (NTSE:FTV). Redwood City, Calif.-based Auris Health, which was created by Intuitive Surgical (NSDQ:ISRG) founder and surgical robotics pioneer Dr. Fred Moll, developed and produces the robotic Monarch platform which has FDA clearance for diagnostic and therapeutic bronchoscopic procedures. The Monarch system features a controller interface for navigating the integrated flexible ro...
Source: Mass Device - April 2, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Robotics Sterilization / Calibration Wall Street Beat johnsonandjohnson Source Type: news

Cancer treatments HARM patients: Radiotherapy can cause aggravated lung injury – study
(Natural News) A Canadian research team announced that it has found the reason for the appearance of pulmonary fibrosis in a number of lung cancer patients who underwent thoracic radiotherapy. They found a connection between genes on a certain chromosome and the development of lung injuries triggered by radiation. The researchers were investigating chromosome 6, one of the 23 pairs... (Source: NaturalNews.com)
Source: NaturalNews.com - April 2, 2019 Category: Consumer Health News Source Type: news

AACR: Pembrolizumab Beneficial for Advanced Small Cell Lung Cancer
TUESDAY, April 2, 2019 -- For patients with advanced small cell lung cancer (SCLC), pembrolizumab shows antitumor activity with durable responses, according to a study presented at the annual meeting of the American Association for Cancer Research,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 2, 2019 Category: Pharmaceuticals Source Type: news

New Approach in Advanced NSCLC: Adding MET Inhibitor Savolitinib New Approach in Advanced NSCLC: Adding MET Inhibitor Savolitinib
In patients with advanced nonsmall cell lung cancer resistant to EGFR inhibitors, adding a MET inhibitor to osimertinib was beneficial, but adding a MEK inhibitor was not.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 1, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Hope restored: Immunotherapy a “game-changer” for mother of two with lung cancer
Jenn Bales calls them “my people.” No, they’re not her children, her boyfriend or her mother. They’re the people who were able to help restore hope in her life. The people who laughed with her, cried with her, and helped fight for her when she was at her lowest point. Her people are her doctors, nurses, advanced clinical practitioners and her entire care team at Atrium Health’s Levine Cancer Institute. And they’re the ones who helped Bales find hope when it looked like there wasn’t… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 1, 2019 Category: American Health Authors: Atrium Health Source Type: news

NGS in Lung Cancers With Insufficient Tumor Samples NGS in Lung Cancers With Insufficient Tumor Samples
How effective is next-generation sequencing of ctDNA for detection of actionable variants in advanced lung cancer?Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 1, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Pembrolizumab Offers New Option in Extensive-Stage Lung Cancer
A pooled analysis of two trials presented at the AACR Annual Meeting looked at the use of pembrolizumab in patients with heavily pretreated extensive small-cell lung cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 1, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Data from two KEYNOTE trials show pembrolizumab benefited patients with advanced SCLC
(American Association for Cancer Research) The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumor activity with durable responses in patients with pretreated, advanced small cell lung cancer (SCLC), according to results from a pooled analysis of the two clinical trials, the phase 1b KEYNOTE-028 and the phase II KEYNOTE-158, presented at the AACR Annual Meeting 2019, March 29-April 3. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2019 Category: Cancer & Oncology Source Type: news

New lung cancer drug combination treats up to 25% of resistant cases
Scientists at Massachusetts General Hospital found that more than half of patients with two forms of treatment resistance saw their lung tumors shrink with a new pairing of targeted drugs. (Source: the Mail online | Health)
Source: the Mail online | Health - March 31, 2019 Category: Consumer Health News Source Type: news

Adding savolitinib to osimertinib beneficial for certain pretreated lung cancer patients
(American Association for Cancer Research) Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who had EGFR-mutant non-small cell lung cancer (NSCLC) that had developed resistance to prior EGFR-targeted therapies through MET-gene amplification, according to interim results from two expansion cohorts of the phase Ib clinical trial TATTON, presented at the AACR Annual Meeting 2019, March 29-April 3. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 31, 2019 Category: Cancer & Oncology Source Type: news

Sexual minorities overlooked in CT lung screening
CT lung screening programs could improve early cancer detection by focusing...Read more on AuntMinnie.comRelated Reading: U.S. cancer sites boast high access to CT lung screening Mental illness may double need for CT lung screening Access to CT lung screening varies by population density CT lung screening may benefit racial minorities most 4 reasons why people seek CT lung cancer screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 29, 2019 Category: Radiology Source Type: news

Predictive Markers for Anti-PD-1/PD-L1 Therapy in NSCLC Predictive Markers for Anti-PD-1/PD-L1 Therapy in NSCLC
What is the current outlook for using predictive markers to guide treatment for patients with NSCLC? What challenges face laboratories implementing these tests?Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 29, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Focus on immunotherapy and patient perspective at IASLC 2019 Small Cell Lung Cancer Meeting
(International Association for the Study of Lung Cancer) While non-small cell lung cancer (NSCLC) is the more common form of lung cancer and attracts the lion's share of the research funding, recent developments in small cell lung cancer may be shifting that slightly. In order to capitalize on these recent developments, researchers who focus on small cell lung cancer (SCLC) will gather in New York City at Memorial Sloan Kettering Cancer April 3-5, 2019, for the IASLC 2019 Small Cell Lung Cancer Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2019 Category: International Medicine & Public Health Source Type: news

Smoking and mortality in Asia
(JAMA Network) In this analysis of data from 20 studies conducted in China, Japan, South Korea, Singapore, Taiwan and India with more than 1 million participants, deaths associated with smoking continued to increase among men in Asia grouped by the years in which they were born. Among the study participants, there were 144,366 deaths (with 9,158 from lung cancer) during an average follow-up of almost 12 years. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 29, 2019 Category: International Medicine & Public Health Source Type: news